MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Korhonen, R.
Right arrow Articles by Moilanen, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Korhonen, R.
Right arrow Articles by Moilanen, E.

Vol. 62, Issue 3, 698-704, September 2002

Dexamethasone Inhibits Inducible Nitric-Oxide Synthase Expression and Nitric Oxide Production by Destabilizing mRNA in Lipopolysaccharide-Treated Macrophages

Riku Korhonen, Aleksi Lahti, Mari Hämäläinen, Hannu Kankaanranta, and Eeva Moilanen

The Immunopharmacological Research Group, Medical School, University of Tampere, Tampere, Finland; and Tampere University Hospital, Tampere, Finland

Nitric oxide (NO) production through the inducible nitric-oxide synthase (iNOS) pathway is increased in inflammatory diseases and leads to cellular injury. Anti-inflammatory steroids inhibit the expression of various inflammatory genes, including iNOS. In the present study, we investigated the mechanism how dexamethasone decreased NO production in murine J774 macrophages. Dexamethasone (0.1-10 µM) inhibited the production of NO and iNOS protein in a dose-dependent manner in cells stimulated with lipopolysaccharides (LPS). In contrast, in cells treated with a combination of LPS and interferon-gamma (IFN-gamma ), dexamethasone did not reduce iNOS expression and NO formation. Dissociated glucocorticoid RU24858 inhibited iNOS expression and NO production to levels comparable with that of dexamethasone, suggesting that the reduced iNOS expression by dexamethasone is not a GRE-mediated event. In further studies, the effect of dexamethasone on iNOS mRNA levels was tested by actinomycin assay. The half-life of iNOS mRNA after LPS treatment was 5 h 40 min, and dexamethasone reduced it to 3 h. The increased degradation of iNOS mRNA was reversed by a protein synthesis inhibitor cycloheximide. iNOS mRNA was more stabile in cells treated with a combination of LPS plus IFN-gamma (half-life = 8 h 20 min), and dexamethasone had a minor effect in these conditions. In conclusion, dexamethasone decreases iNOS-dependent NO production by destabilizing iNOS mRNA in LPS-treated cells by a mechanism that requires de novo protein synthesis. Also, decreased iNOS mRNA and protein expression and NO formation by dexamethasone was not found in cells treated with a combination of LPS plus IFN-gamma , suggesting that the effect of dexamethasone is stimulus-dependent.


Copyright © 2002 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
O. Sareila, M. Hamalainen, E. Nissinen, H. Kankaanranta, and E. Moilanen
Orazipone Inhibits Activation of Inflammatory Transcription Factors Nuclear Factor-{kappa}B and Signal Transducer and Activator of Transcription 1 and Decreases Inducible Nitric-Oxide Synthase Expression and Nitric Oxide Production in Response to Inflammatory Stimuli
J. Pharmacol. Exp. Ther., February 1, 2008; 324(2): 858 - 866.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
T. H. Mogensen, R. S. Berg, S. R. Paludan, and L. Ostergaard
Mechanisms of Dexamethasone-Mediated Inhibition of Toll-Like Receptor Signaling Induced by Neisseria meningitidis and Streptococcus pneumoniae
Infect. Immun., January 1, 2008; 76(1): 189 - 197.
[Abstract] [Full Text] [PDF]


Home page
The Annals of PharmacotherapyHome page
R. P Miech
Pathopharmacology of Excessive Hemorrhage in Mifepristone Abortions
Ann. Pharmacother., December 1, 2007; 41(12): 2002 - 2007.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
R. Newton and N. S. Holden
Separating Transrepression and Transactivation: A Distressing Divorce for the Glucocorticoid Receptor?
Mol. Pharmacol., October 1, 2007; 72(4): 799 - 809.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
O. A. Huynh, T. Hampartzoumian, J. P. Arm, J. Hunt, L. Borges, M. Ahern, M. Smith, C. L. Geczy, H. P. McNeil, and N. Tedla
Down-regulation of leucocyte immunoglobulin-like receptor expression in the synovium of rheumatoid arthritis patients after treatment with disease-modifying anti-rheumatic drugs
Rheumatology, May 1, 2007; 46(5): 742 - 751.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
Y. Wada, R. Lu, D. Zhou, J. Chu, T. Przewloka, S. Zhang, L. Li, Y. Wu, J. Qin, V. Balasubramanyam, et al.
Selective abrogation of Th1 response by STA-5326, a potent IL-12/IL-23 inhibitor
Blood, February 1, 2007; 109(3): 1156 - 1164.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
J. E. Chivers, W. Gong, E. M. King, J. Seybold, J. C. Mak, L. E. Donnelly, N. S. Holden, and R. Newton
Analysis of the Dissociated Steroid RU24858 Does Not Exclude a Role for Inducible Genes in the Anti-Inflammatory Actions of Glucocorticoids
Mol. Pharmacol., December 1, 2006; 70(6): 2084 - 2095.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. Ayaori, S. Sawada, A. Yonemura, N. Iwamoto, M. Ogura, N. Tanaka, K. Nakaya, M. Kusuhara, H. Nakamura, and F. Ohsuzu
Glucocorticoid Receptor Regulates ATP-Binding Cassette Transporter-A1 Expression and Apolipoprotein-Mediated Cholesterol Efflux From Macrophages
Arterioscler. Thromb. Vasc. Biol., January 1, 2006; 26(1): 163 - 168.
[Abstract] [Full Text] [PDF]


Home page
Proc Am Thorac SocHome page
C. Stellato
Post-transcriptional and Nongenomic Effects of Glucocorticoids
Proceedings of the ATS, November 1, 2004; 1(3): 255 - 263.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
E. Rapizzi, S. Fossati, F. Moroni, and A. Chiarugi
Inhibition of Poly(ADP-Ribose) Glycohydrolase by Gallotannin Selectively Up-Regulates Expression of Proinflammatory Genes
Mol. Pharmacol., October 1, 2004; 66(4): 890 - 898.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
K. V. Reddy, G. Bhattacharjee, G. Schabbauer, A. Hollis, K. Kempf, M. Tencati, M. O'Connell, M. Guha, and N. Mackman
Dexamethasone enhances LPS induction of tissue factor expression in human monocytic cells by increasing tissue factor mRNA stability
J. Leukoc. Biol., July 1, 2004; 76(1): 145 - 151.
[Abstract] [Full Text] [PDF]


Home page
Arch. Dis. Child. Fetal Neonatal Ed.Home page
O Williams, R Y Bhat, P Cheeseman, G F Rafferty, S Hannam, and A Greenough
Exhaled nitric oxide in chronically ventilated preterm infants
Arch. Dis. Child. Fetal Neonatal Ed., January 1, 2004; 89(1): F88 - F89.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
A. Lahti, U. Jalonen, H. Kankaanranta, and E. Moilanen
c-Jun NH2-Terminal Kinase Inhibitor Anthra(1,9-cd)pyrazol-6(2H)-one Reduces Inducible Nitric-Oxide Synthase Expression by Destabilizing mRNA in Activated Macrophages
Mol. Pharmacol., August 1, 2003; 64(2): 308 - 315.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2002 by the American Society for Pharmacology and Experimental Therapeutics